Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE WIRB-Copernicus Group
PRINCETON, N.J., Oct. 8, 2013 /PRNewswire/ -- The WIRB-Copernicus Group ("WCG"), the world's largest provider of regulatory and ethical review services for clinical research, today announced the recent appointment of Lindsay McNair, M.D., M.P.H., M.S.B., to the new position of Chief Clinical Research Officer. Dr. McNair will be responsible for developing strategic partnerships and will oversee WCG's Consulting Division supporting pharmaceutical and biotechnology companies, providing expert advice on matters related to clinical trial design, study startup and ethical policies. Dr. McNair will be based out of WCG's headquarters in Princeton, NJ.
"Dr. McNair is an extraordinary physician who has had direct experience in organizing and conducting clinical research. She understands the requirements and challenges that our clients face," stated Donald A. Deieso, Ph.D., Executive Chairman of the WIRB-Copernicus Group. "Her years in clinical development and as a consultant have given her the type of comprehensive perspective on the ethical review process that we need to lead our clinical research review efforts. This experience adds important dimensions to our capabilities as we expand our portfolio of services."
For more than 13 years, Dr. McNair has been actively involved with Institutional Review Boards ("IRBs"). Prior to joining WCG, she acted as a consultant to pharmaceutical and biotechnology companies, providing medical guidance on clinical development strategies and designs for new drug studies, as well as handling medical oversight of all phases of clinical trials. She has worked with the Association for the Accreditation of Human Research Protection Programs ("AAHRPP") to perform on-site evaluations and inspections of HRPP and IRB programs to ensure that standards for accreditation were met. Previously, she served as Senior Director of Medical Affairs at Vertex Pharmaceuticals and Director of Medical Affairs/Medical Operations at Antigenics, Inc.
"I am honored to join the WIRB-Copernicus Group at a time when the Company is driving so many exciting new initiatives to change the way the industry approaches the independent review process; I look forward to continuing to lead this evolution," stated Dr. McNair. "WCG has assembled an extremely talented team of top industry experts, and we will work together to continue to improve ethical review practices around the globe."
Dr. McNair is an adjunct faculty member at Boston University and teaches graduate-level courses on the scientific design of clinical research studies and the development of clinical study protocols. She holds a Master's of Science in Bioethics (M.S.B.) degree, with a concentration in Research Ethics, from Union Graduate College; a Master's of Public Health (M.P.H.) degree from the Boston University School of Public Health; received her Doctor of Medicine (M.D.) degree from the University of Connecticut School of Medicine; and has a Bachelor of Science (B.S.) degree in Biology from Trinity College.
In addition, Dr. McNair is currently the Associate Editor and an Editorial Board member of the Journal of Empirical Research on Human Research Ethics, a peer reviewer for the Journal of Law, Medicine and Ethics, and a member of the Ethics Committee for the Hospice of the North Shore and Greater Boston.
About The WIRB-Copernicus Group
Transforming Ethical Review
The WIRB-Copernicus Group (WCG) is the world's largest provider of regulatory and ethical review services for human research. With eight individual AAHRPP-accredited panels, over 100 experienced board members, and over 60 years of combined experience in protocol and study-related review, the WIRB-Copernicus Group brings more expertise to the industry than any other ethical solutions provider.
Members of the WIRB-Copernicus Group family of companies include Western Institutional Review Board (WIRB) and Copernicus Group IRB (CGIRB), the nation's leading independent institutional review boards, and IRBNet, the top research compliance software supporting institutions. It is the mission of the WIRB-Copernicus Group to meet the highest standards of ethics and science, and to ensure the safety and welfare of research subjects worldwide. For more information, please visit www.wcgirb.com.
©2012 PR Newswire. All Rights Reserved.